New Arthritis Drug Helps Treatment-Resistant Depression
Summary: A pilot randomized, controlled clinical trial provides the first targeted clinical evidence that immunotherapy may offer a new treatment avenue for people with treatment-resistant depression. The study tested whether tocilizumab, an anti-inflammatory drug commonly used for autoimmune conditions such as rheumatoid arthritis, can relieve depressive symptoms by blocking a specific inflammatory pathway. By selecting … Read more